Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)Depreciation ExpenseEBIATGross ProfitLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

Evolus (EOLS) Shares Issued (2018 - 2025)

Evolus filings provide 7 years of Shares Issued readings, the most recent being -$1.1 million for Q4 2025.

  • On a quarterly basis, Shares Issued rose 97.66% to -$1.1 million in Q4 2025 year-over-year; TTM through Mar 2026 was -$742000.0, a 98.21% increase, with the full-year FY2024 number at $4.9 million, changed N/A from a year prior.
  • Shares Issued hit -$1.1 million in Q4 2025 for Evolus, down from $1.1 million in the prior quarter.
  • In the past five years, Shares Issued ranged from a high of $47.0 million in Q1 2024 to a low of -$46.3 million in Q4 2024.
  • Median Shares Issued over the past 5 years was $43000.0 (2023), compared with a mean of $337555.6.
  • The widest YoY moves for Shares Issued: up 180684.62% in 2024, down 23658.46% in 2024.
  • Evolus' Shares Issued stood at $1000.0 in 2021, then soared by 35400.0% to $355000.0 in 2022, then plummeted by 154.93% to -$195000.0 in 2023, then crashed by 23658.46% to -$46.3 million in 2024, then skyrocketed by 97.66% to -$1.1 million in 2025.
  • The last three reported values for Shares Issued were -$1.1 million (Q4 2025), $1.1 million (Q3 2025), and -$742000.0 (Q2 2025) per Business Quant data.